MYND Life Sciences Inc. (MYND.CN)
CAD 0.07
(-30.0%)
CAD 0.07
(-30.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -1.51 Million CAD | 57.45% |
| 2022 | -3.56 Million CAD | 18.32% |
| 2021 | -4.36 Million CAD | -7634.21% |
| 2020 | -56.46 Thousand CAD | -2127.46% |
| 2019 | -2535.00 CAD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -259.56 Thousand CAD | 30.37% |
| 2024 Q1 | -372.76 Thousand CAD | -179.47% |
| 2024 Q3 | -379.27 Thousand CAD | -46.12% |
| 2023 Q4 | 469.03 Thousand CAD | 188.37% |
| 2023 Q2 | -617.61 Thousand CAD | 40.12% |
| 2023 Q1 | -1.03 Million CAD | -86.55% |
| 2023 FY | -1.51 Million CAD | 57.45% |
| 2023 Q3 | -530.77 Thousand CAD | 14.06% |
| 2022 Q3 | -1.02 Million CAD | -0.57% |
| 2022 Q2 | -1.01 Million CAD | 22.54% |
| 2022 Q1 | -1.31 Million CAD | 14.32% |
| 2022 FY | -3.56 Million CAD | 18.32% |
| 2022 Q4 | -552.88 Thousand CAD | 45.86% |
| 2021 Q3 | -868.47 Thousand CAD | -11.6% |
| 2021 FY | -4.36 Million CAD | -7634.21% |
| 2021 Q2 | -778.21 Thousand CAD | 34.63% |
| 2021 Q4 | -1.53 Million CAD | -76.17% |
| 2021 Q1 | -1.19 Million CAD | 0.0% |
| 2020 FY | -56.46 Thousand CAD | -2127.46% |
| 2019 FY | -2535.00 CAD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Algernon Pharmaceuticals Inc. | -6.78 Million CAD | 77.617% |
| Asep Medical Holdings Inc | -8.22 Million CAD | 81.551% |
| BetterLife Pharma Inc. | -2.88 Million CAD | 47.461% |
| BioVaxys Technology Corp. | -7.68 Million CAD | 80.255% |
| ChitogenX Inc. | -1.55 Million CAD | 2.326% |
| Rapid Dose Therapeutics Corp. | -4.3 Million CAD | 64.754% |
| Defence Therapeutics Inc. | -13.19 Million CAD | 88.495% |
| Entheon Biomedical Corp. | -300 Thousand CAD | -405.952% |
| Gemina Laboratories Ltd. | -5.21 Million CAD | 70.904% |
| Glow Lifetech Corp. | -1.64 Million CAD | 7.763% |
| Lexston Life Sciences Corp. | -867.71 Thousand CAD | -74.927% |
| Pharmala Biotech Holdings Inc. | -779.81 Thousand CAD | -94.644% |
| Doseology Sciences Inc. | -339.84 Thousand CAD | -346.629% |
| Nova Mentis Life Science Corp. | -1.22 Million CAD | -23.965% |
| PharmaTher Holdings Ltd. | -3.11 Million CAD | 51.278% |
| PreveCeutical Medical Inc. | -1.27 Million CAD | -19.097% |
| Telescope Innovations Corp. | -5.72 Million CAD | 73.498% |